Donald Gleason Conference on Genitourinary Malignancies

Format: Live Webinar

This course is planned and hosted by the University of Minnesota, Department of Urology. 

This conference brings together top-notch faculty to share updates and best practices in the interest of advancing our collective knowledge related to early diagnosis, proper staging, and effective treatment of urologic cancers.

1. Identify new approaches for diagnosis and treatment of urologic cancers.
2. Describe the latest therapeutic interventions for urologic cancers.
3. Describe emerging concepts in treatment of advanced urologic cancers.
4. Explain the biology of urologic cancers.
5. Outline strategies for patient discussions regarding the risks and benefits of new and evolving treatment options for urologic cancers.

Credit Designation Statements

American Medical Association (AMA)
The University of Minnesota, Interprofessional Continuing Education designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

American Nurses Credentialing Center (ANCC)
This activity is awarded up to 5.5 ANCC contact hours.

Other Healthcare Professionals
Other healthcare professionals who participate in this CE activity may submit their statement of participation to their appropriate accrediting organizations or state boards for consideration of credit. The participant is responsible for determining whether this activity meets the requirements for acceptable continuing education.

Cancellation Policy
If you need to cancel your registration, the registration fee, less a $50 administrative fee, will be refunded if we receive a two-week notice prior to the activity. No refunds will be made after that. 

UMN Office of Continuing Professional Development (OCPD) and/or our partner in providing the activity reserves the right to cancel any activity due to unforeseen circumstances. In the event the activity is cancelled, registration fees will be refunded. UMN OCPD and/or our partner in providing the activity is not responsible for any travel-related costs, charges, or expenses, including but not limited to fees assessed by airline, travel, or lodging agencies.

Special Needs Requests
Special needs can be indicated when registering for an activity. If you missed the special needs field, please email [email protected] with your special needs request as well as the activity you will be attending. Please note requests cannot always be honored on-site.

Mitigation of Relevant Financial Relationships

University of Minnesota Continuing Professional Development adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education and has policies in place to ensure balance, independence, objectivity and scientific rigor in all of its educational activities. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible entities (commercial interests); individuals who fail to complete the disclosure in advance of the course are not eligible to be involved in this course. Specific disclosure information will be shared with learners prior to the start of the course. All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Casey Pratt, BA
University of Minnesota

Activity Coordinator

Nothing to disclose

Christopher Warlick, MD, PhD
University of Minnesota

Course Director, Faculty

I am the PI on a trial for Francis Medical-Francis Medical|Salary-Syros

Hamed Ahmadi, MD
University of Minnesota

Faculty

Nothing to disclose

Emmanuel S Antonarakis, MD
University of Minnesota

Faculty

Consulting Fee-Amgen|Consulting Fee-Astellas|Consulting Fee-AstraZeneca|Consulting Fee-Bayer Corporation|Research Grant Recipient-Bristol-Myers Squibb|Research Grant Recipient-Celgene|Consulting Fee-Clovis|Consulting Fee-Dendreon|Consulting Fee-Eli Lilly and Company|Consulting Fee-ESSA|Research Grant Recipient-Genentech, Inc.|Consulting Fee-GlaxoSmithKline|Consulting Fee-Janssen|Research Grant Recipient-Johnson and Johnson|Consulting Fee-Medivation|Consulting Fee-Merck and Company, Inc.|Research Grant Recipient-Novartis AG|Receipt of Intellectual Property Rights/Patent Holder-Qiagen|Consulting Fee-Sanofi-Aventis|Research Grant Recipient-Tokai

Brent E Cleveland, MD
Dr.
University of Minnesota

Faculty

Nothing to disclose

Justin Drake, PhD
Dr.
University of Minnesota

Faculty

Nothing to disclose

Shilpa Gupta, MD
Cleveland Clinic Foundation

Faculty

Consulting Fee-Gilead|Consulting Fee-EMD Serono-EMD Serono Inc|Consulting Fee-Johnson and Johnson|Consulting Fee-Bristol-Myers Squibb|Speakers Bureau-Janssen|Speakers Bureau-Seattle Genetics

Elaine T Lam, MD, FACP
Associate Professor
University of Colorado

Faculty

Consulting Fee-Calithera Biosciences|Contracted Research-Bristol-Myers Squibb|Contracted Research-Merck and Company, Inc.|Contracted Research-Roche|Contracted Research-Arrowhead|Contracted Research-Pfizer, Inc.

Rachel A Mann, MD
University of Minnesota

Faculty

Nothing to disclose

Kelvin A Moses, MD, PhD, FACS
Dr.
Vanderbilt University Medical Center

Faculty

Speakers Bureau-Pfizer, Inc.

Drew Rosielle, MD, FAAHPM
Associate Professor
M Health Fairview

Faculty

Nothing to disclose

B. R. Simon Rosser, PhD
Prof.
University of Minnesota

Faculty

Nothing to disclose

Thomas Stout, MD
Resident
University of Minnesota

Faculty

Nothing to disclose

Ellen Thompson, MD
U of M

Faculty

Nothing to disclose

Phuoc Tran, MD, PhD
Professor
Johns Hopkins Medicine

Faculty

Consulting Fee-Johnson and Johnson|Consulting Fee-RefleXion Medical|Consulting Fee-AstraZeneca|Consulting Fee-Myovant|Contracted Research-Bayer Corporation|Contracted Research-Astellas|Royalty-Natsar Pharm

Robert Turesky, PhD
University of Minnesota

Faculty

Nothing to disclose

Subodh K Regmi, MBBS, Assistant Professor
University of Minnesota

Faculty, Planning Committee Member

Nothing to disclose

Michael Risk, MD, PhD
University of Minnesota

Faculty, Planning Committee Member

Nothing to disclose

Joseph Zabell, MD
University of Minnesota

Faculty, Planning Committee Member

Nothing to disclose

Jessica Tanner, RN
RN
M Health Fairivew

Nurse Planner

Nothing to disclose

L. Chinsoo Cho, MD
UMN

Planning Committee Member

Nothing to disclose

Philipp Dahm, MD
UMN

Planning Committee Member

Nothing to disclose

Scott Dehm, PhD
University of Minnesota

Planning Committee Member

Consulting Fee-Bristol-Myers Squibb|Consulting Fee-Johnson and Johnson|Consulting Fee-Oncternal Therapeutics

Charles Ryan, MD

Planning Committee Member

Consulting Fee-Advanced Accelerator Applications|Consulting Fee-Roivant|Consulting Fee-Pfizer, Inc.|Consulting Fee-Dendreon|Contracted Research-Clovis Oncology|Contracted Research-Sanofi-Genzyme|Research Grant and Consultant-Bayer Corporation

Friday, October 15, 2021

View Online Exhibit Portfolio

Exhibitor Breakout Room Details